Aurobindo Pharma Limited
AUROPHARMA
Rank in Stocks
#2030
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Share Price
$17.83
Market Cap
$10.26B
Change (1 day)
-2.62%
Change (1 year)
42.55%
Country
IN
Trade Aurobindo Pharma Limited (AUROPHARMA)
Category
Healthcare
Operating Margin for Aurobindo Pharma Limited (AUROPHARMA)
Operating Margin as of October 2026 TTM: 15.12%
According to Aurobindo Pharma Limited latest financial reports and stock price the company's current Operating Margin (TTM) is 15.12%. At the end of 2024 the company had an Operating Margin of 36.03%.
Operating Margin history for Aurobindo Pharma Limited from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 15.12% | -60.03% |
| 2025 | 37.83% | 5.00% |
| 2024 | 36.03% | 244.46% |
| 2023 | 10.46% | -26.60% |
| 2022 | 14.25% | -19.90% |
| 2021 | 17.79% | 2.65% |
| 2020 | 17.33% | 2.48% |
| 2019 | 16.91% | -16.16% |
| 2018 | 20.17% | -2.80% |
| 2017 | 20.75% | -0.53% |
| 2016 | 20.86% | 7.86% |
| 2015 | 19.34% | -17.14% |
| 2014 | 23.34% | 94.50% |
| 2013 | 12.00% | 25.39% |
| 2012 | 9.57% | -49.15% |
| 2011 | 18.82% | -17.96% |
| 2010 | 22.94% | 305.30% |
| 2009 | 5.66% | -58.90% |
| 2008 | 13.77% | 16.30% |
| 2007 | 11.84% | 45.99% |
| 2006 | 8.11% | 57.17% |
| 2005 | 5.16% | -60.73% |
| 2004 | 13.14% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -98.48% |
IN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.